
El-Life Medi Pharma Limited
Founded in 2016 and headquartered in Rajasthan, India.
Founded in 2016 and headquartered in Rajasthan, India.
Jaipur, Rajasthan, India
+91-XXXXXXXXXX
U74999RJ2016PLC056530
056530
Public Limited Indian Non-Government Company
14 Dec 2016
12 Jul 2019
31 Mar 2019
Unlisted
Roc Jaipur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Jain ![]() | Director | 14-Dec-2016 | Current |
Sandeep Jain ![]() | Director | 14-Dec-2016 | Current |
Mahipal Singh ![]() | Director | 14-Dec-2016 | Current |
El-Life Medi Pharma Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, El-Life Medi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sandeep Jain is a mutual person
Sandeep Jain is a mutual person
₹0
₹1.00 M
Date | Lender | Amount | Status |
---|---|---|---|
09 Jan 2017 | Others | ₹1.00 M | Satisfied |
Unlock and access historical data on people associated with El-Life Medi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of El-Life Medi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped El-Life Medi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
El-Life Medi Pharma Limited last Annual general meeting of members was held on 12 Jul 2019 as per latest MCA records.
El-Life Medi Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Jaipur.
A charge registered on 09 Jan 2017 via Charge ID 100107815 with Others was fully satisfied on 28 Mar 2019.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100107815 was registered on 09 Jan 2017.
Sanjay Jain was appointed as a Director was appointed as a Director on 14 Dec 2016 & has been associated with this company since 8 years 4 months .
Sandeep Kumar Jain was appointed as a Director was appointed as a Director on 14 Dec 2016 & has been associated with this company since 8 years 4 months .
El-Life Medi Pharma Limited was incorporated on 14 Dec 2016.
The authorized share capital of El-Life Medi Pharma Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 3 directors are associated with El-Life Medi Pharma Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of El-Life Medi Pharma Limited is 61/174 Rajat Path Mansarovar, India, Jaipur, Rajasthan, 302020.
The corporate identification number (CIN) of El-Life Medi Pharma Limited is U74999RJ2016PLC056530 and the company number is 056530 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for El-Life Medi Pharma Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.